COVID-19 vaccine weekly safety report (14 April 2022)

TGA

14 April 2022 - To 10 April 2022, the TGA has received 528 reports which have been assessed as likely to be myocarditis from about 38.9 million doses of Comirnaty (Pfizer) and 84 reports which have been assessed as likely to be myocarditis from about 4.1 million doses of Spikevax (Moderna).

No new cases of thrombosis with thrombocytopenia syndrome related to the AstraZeneca vaccine have been reported this year.

Read TGA News

Michael Wonder

Posted by:

Michael Wonder